Solabia Joins Forces with Astorg for Global Expansion
Deal News | May 07, 2025 | TA Associates
Astorg, an established pan-European private equity firm, has entered into a definitive agreement to acquire a majority stake in Solabia Group, a biotechnology solution provider. TA Associates, the current major stakeholder, will reinvest along with Astorg to support Solabia's growth strategy focusing on international expansion, particularly in the US and Asia, and product innovation. Solabia specializes in developing natural active ingredients utilized across several industries including cosmetics and pharmaceuticals, setting itself apart with advanced biotechnology capabilities. The three entities - Astorg, TA, and Solabia's management - aim to leverage Solabia's strong market position and continue its double-digit growth trend. The transaction awaits regulatory approval and is expected to close in upcoming months. Financial specifics remain undisclosed.
Sectors
- Private Equity
- Biotechnology
- Pharmaceuticals and Cosmetics
Geography
- Europe – Astorg is a pan-European private equity firm, and Solabia is headquartered in Paris, indicating a European geographical focus.
- United States – The international expansion plan includes a particular focus on the US market.
- Asia – The global expansion strategy targets growth in Asia as well.
Industry
- Private Equity – The article involves private equity firms Astorg and TA Associates acquiring stakes in a biotechnology company.
- Biotechnology – Solabia is a biotechnology ingredient solutions provider focusing on natural active ingredients, making the biotechnology sector relevant.
- Pharmaceuticals and Cosmetics – Solabia develops natural active ingredients used in cosmetics and pharmaceuticals, highlighting its relevance to these industries.
Financials
- Not disclosed – The financial terms of the transaction were not disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Solabia Group | Target | Company | A global biotechnology ingredient solutions provider, specializing in natural active ingredients. |
| TA Associates | Selling Company, Reinvestor | Company | A leading global private equity firm and exiting majority stakeholder in Solabia. |
| Astorg | Bidding Company | Company | A leading pan-European private equity firm acquiring a majority stake in Solabia. |
| Evercore | Financial Advisor to Astorg | Company | Advised Astorg on the financial aspects of the deal. |
| Wil Partners | Financial Advisor to Astorg | Company | Provided financial advisory services to Astorg. |
| Weil Gotshal & Manges | Legal Advisor to Astorg | Company | Provided legal counsel to Astorg for the transaction. |
| Sycomore | Financial Advisor to Solabia Management | Company | Advised Solabia's management on financial matters related to the transaction. |
| Jeausserand-Audouard | Legal & Tax Advisors to Solabia Management | Company | Provided legal and tax advisory services to Solabia's management team. |
| BofA Securities | Financial Advisor to TA Associates | Company | Advised TA Associates on the financial aspects of the transaction. |
| Latham & Watkins | Legal Advisor to TA Associates | Company | Provided legal counsel to TA Associates for the transaction. |
| Jean-Baptiste Dellon | President & CEO | Person | President and Chief Executive Officer of Solabia Group. |
| Nicolas Marien | Partner | Person | Partner at Astorg involved in the transaction. |
| Paul Arhanchiague | Managing Director | Person | Managing Director at Astorg involved in the transaction. |
| Patrick Sader | Managing Director | Person | Managing Director at TA Associates involved in the transaction. |
| Jrmy Dran | Director | Person | Director at TA Associates involved in the transaction. |